John

Marsden

John Marsden is an academic and practitioner psychologist, board certified with the British Psychological Society, and the British Association for Cognitive and Behavioural Psychotherapies. He is Professor of Addiction Psychology and Deputy Head of Department for Addictions, School of Academic psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King’s College London (KCL), United Kingdom. He is Editor-in-Chief of the scientific journal ADDICTION. John’s academic focus is on the development and evaluation of novel pharmacological and psychological therapies for substance use disorders, psychiatric and public health epidemiology, and psychometrics. He is Senior Academic Advisor at the Office for Health Inclusion and Disparities, Department of Health and Social Care, and a clinical academic consultant to the US NIDA Centre for the Clinical Trials Network. His recent research includes randomised controlled trials of personalised psychosocial interventions in treatment-resistant opioid use disorder (OUD) long-acting injectable buprenorphine for OUD (investigator-initiated [sponsor: KCL] by Indivior), and a Phase IIa safety and feasibility study of 5-MeO-DMT for alcohol use disorder (commercial sponsor: Beckley PsyTech).